HempTalk - Business Blogs and Press Releases
Project CBD Newsletter: Trump’s Cannabis Rescheduling Reality, CBD for Wound Healing and Rheumatoid Arthritis, Medical Cannabis for Migraines, and Rare Cannabis Compounds
This week’s newsletter covers the limited scope of Trump’s cannabis rescheduling announcement, new research on CBD’s potential in wound healing and rheumatoid arthritis, a longitudinal study on medical cannabis for migraine patients, and the discovery of rare compounds in cannabis leaves.
Noteworthy Read
Trump’s Marijuana Rescheduling: Big Headlines, Narrower Reality (DC Report)
In this article, DCReport breaks down the limits of the Trump administration’s recent cannabis rescheduling move, noting that the policy shift will primarily leave adult-use markets, banking access, and many criminal justice issues unresolved.
Read the article
View more in THC
More Noteworthy Reading
Cannabis Leaves Have Rare Compounds With Medical Potential (ScienceDaily)
Researchers at Stellenbosch University identified rare flavoalkaloids in cannabis leaves, including compounds not previously reported in the plant. The findings point to underexplored biomedical potential in cannabis biomass that is often treated as agricultural waste, though the work remains in its early stages.
Read more
View more in Endocannabinoid System
CBD for Soft Tissue Wound Healing (PubMed)
A new review examines how cannabidiol may influence the molecular and cellular processes involved in soft tissue wound healing, including inflammation, oxidative stress, angiogenesis, and tissue repair. The paper frames CBD as a promising therapeutic candidate, while emphasizing that stronger clinical evidence is still needed before its role in wound care can be clearly established.
Medical Cannabis for Migraine Patients (NORML)
A longitudinal study of migraine patients using medical cannabis products found sustained improvements in pain, disability, sleep, anxiety, depression, and overall quality of life. The real-world findings add to evidence that cannabis may help some migraine patients manage symptoms over time, though product type, THC content, and patient-specific responses remain important variables.
Research Round-Up
CBD Synergizes With Methotrexate to Attenuate Rheumatoid Arthritis (International Immunopharmacology)
A preclinical study found that cannabidiol enhanced methotrexate’s antiarthritic effects. The findings suggest a possible cannabinoid-based strategy for rheumatoid arthritis, but human studies are needed to determine whether the combination is safe or clinically useful.
Read more
View more in Drug Interactions
A heartfelt thank you to all of the CBD brands whose generous support makes it possible for Project CBD to continue bringing you the latest in plant medicine research and cannabis science.
The post Project CBD Newsletter: Trump’s Cannabis Rescheduling Reality, CBD for Wound Healing and Rheumatoid Arthritis, Medical Cannabis for Migraines, and Rare Cannabis Compounds appeared first on Project CBD.
